Valuation : ResMed, Inc.

Market Cap 33.37B 28.79B 27.08B 24.67B 46.39B 3,167B 46.64B 320B 125B 1,611B 125B 123B 5,342B P/E 2027 *
20.1x
P/E 2028 * 18.1x
Enterprise Value 32.43B 27.97B 26.31B 23.97B 45.08B 3,078B 45.32B 311B 121B 1,565B 122B 119B 5,191B EV / Sales 2027 *
5.57x
EV / Sales 2028 * 5.11x
Free-Float
75.13%
Yield 2027 *
1.15%
Yield 2028 * 1.26%
1 day-3.64%
1 week-2.21%
Current month-3.64%
1 month+9.66%
3 months+24.09%
6 months-9.72%
Current year-3.95%
1 week 230.18
Extreme 230.175
242.4
1 month 202
Extreme 202
242.4
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
284.87
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap. Importance
7/8/26 Exercice

Chief Executive Officer

14,973 0.0103%
5/8/26 Sell

Founder

-8,000 0.0055%
7/7/26 Exercice

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-3.64%-2.21%-15.72%+45.34% 33.37B
-2.69%-4.40%+21.87%+7.77% 222B
-3.10%-4.19%+0.54%-22.09% 145B
-2.02%-0.70%-21.98%+18.96% 130B
-0.46%-3.57%-54.43%-10.33% 69.68B
-0.01%-0.14%+11.56%+18.80% 52.3B
-0.60%-0.56%-15.61%-14.33% 50.71B
-2.36%-3.13%+19.31%+22.98% 42.28B
-2.12%-2.08%+34.47%+44.42% 39.87B
-3.04%-7.94%+107.21%+22.96% 31.28B
Average -1.12%-1.54%+8.72%+13.45% 81.74B
Weighted average by Cap. -0.84%-1.69%+3.80%+6.72%

Financials

2027 *2028 *
Net sales 5.82B 5.02B 4.72B 4.3B 8.09B 552B 8.13B 55.81B 21.72B 281B 21.84B 21.37B 931B 6.2B 5.35B 5.03B 4.58B 8.62B 588B 8.66B 59.46B 23.14B 299B 23.27B 22.77B 992B
Net income 1.63B 1.4B 1.32B 1.2B 2.26B 155B 2.28B 15.62B 6.08B 78.62B 6.11B 5.98B 261B 1.78B 1.54B 1.45B 1.32B 2.48B 169B 2.49B 17.1B 6.65B 86.04B 6.69B 6.55B 285B
Net Debt -947M -817M -769M -700M -1.32B -89.9B -1.32B -9.09B -3.54B -45.73B -3.56B -3.48B -152B -1.69B -1.45B -1.37B -1.25B -2.34B -160B -2.36B -16.18B -6.3B -81.41B -6.33B -6.19B -270B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
11,370
Date Price Change Volume
01/09/26 US$231.36 -3.64% 987,078
31/08/26 US$240.10 -0.10% 1,722,128
28/08/26 US$240.33 +1.94% 1,386,748
27/08/26 US$235.76 +0.03% 1,588,523
26/08/26 US$235.69 -0.38% 1,542,343
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
231.36USD
Average target price
246.25USD
Spread / Average Target
+6.44%

Quarterly revenue - Rate of surprise